Value of Liquid Potassium Magnesium Citrate in Controlling Hypertension
Status:
Completed
Trial end date:
2015-03-01
Target enrollment:
Participant gender:
Summary
Liquid potassium-magnesium citrate (KMgCit) as a pharmaceutical formulation will lower blood
pressure among patients with pre- or Stage I hypertension on their customary diet.
Phase:
Phase 2
Details
Lead Sponsor:
Meta Pharm Development, LLC University of Texas Southwestern Medical Center